05:27 PM EDT, 05/24/2024 (MT Newswires) -- Jerome B Zeldis, Director, on May 22, 2024, sold 20,000 shares in Ptc Therapeutics ( PTCT ) for $764,800. Following the Form 4 filing with the SEC, Zeldis has control over a total of 14,500 shares of the company, with 14,500 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1070081/000141588924014552/xslF345X03/form4-05242024_050501.xml